MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Cytokinetics, Incorporated Historical Prices 2011-2026 | CYTK
Annual Historical Prices Cytokinetics, Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.3 | 73.6 | 43.2 | 45.6 | 20.8 | 10.6 | 6.32 | 8.15 | 12.2 | 10.5 | 8.01 | 6.5 | 3.96 | 5.76 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 73.6 | 3.96 | 21.6 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K |  USA |
 |
Adagene
ADAG
|
1.56 | $ 2.4 | -3.61 % | $ 135 M |  China |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.97 | 0.81 % | $ 5.29 M | China |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.62 | 1.91 % | $ 8.71 B |  Australia |
 |
Biogen
BIIB
|
133 | $ 172.5 | 0.53 % | $ 25.1 B | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 117.41 | 1.23 % | $ 27.2 B | Germany |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Catalyst Biosciences
CBIO
|
0.51 | $ 12.1 | -5.47 % | $ 797 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Cellectis S.A.
CLLS
|
1.27 | $ 4.16 | -5.88 % | $ 116 M | France |
 |
BioXcel Therapeutics
BTAI
|
2.12 | $ 1.79 | -1.92 % | $ 4.54 M | USA |
 |
BioLineRx Ltd.
BLRX
|
2.65 | $ 2.98 | -3.75 % | $ 908 M |  Israel |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 231.73 | -1.55 % | $ 5 B |  Danmark |
 |
Burford Capital Limited
BUR
|
10.6 | $ 9.72 | -0.31 % | $ 1.57 B | Britain |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M |  Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
46.7 | $ 67.09 | 0.06 % | $ 8.97 B | USA |
 |
Compugen Ltd.
CGEN
|
1.65 | $ 2.05 | -2.15 % | $ 184 M | Israel |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 4.41 | -1.34 % | $ 9.6 B | Israel |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
27 | $ 26.4 | 1.85 % | $ 1.28 B | USA |
 |
Coherus BioSciences
CHRS
|
2.22 | $ 2.27 | 10.19 % | $ 214 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
5.91 | $ 13.54 | 1.12 % | $ 4.18 B | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
Celldex Therapeutics
CLDX
|
20.4 | $ 26.48 | 2.16 % | $ 1.71 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.73 | 1.11 % | $ 17.1 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
AstraZeneca PLC
AZN
|
74.2 | $ 94.12 | 1.25 % | $ 96.9 B | Britain |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |